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Background: Low cardiorespiratory fitness is associated with increased risk of hypertension and
atherosclerosis in adults with prehypertension. The purpose of this study was to quantify
cardiorespiratory fitness and to examine the utility of supramaximal constant-load verification
testing for validating maximal oxygen uptake (VO ) attainment in adults with
prehypertension. Methods: Eleven adults (four women) with prehypertension (22.5 ± 2.9 y; body
mass index (BMI): 24.6 ± 3.2 kg·m ) underwent an incremental exercise test followed 15 min
later by a verification test at 105% of maximal work rate on a cycle ergometer. Results: There
was no statistical difference in VO  between the incremental (2.23 ± 0.54 L·min ) and
verification tests (2.28 ± 0.54 L·min ; p = 0.180). Only three out of eleven participants had a
higher VO  during the verification when compared with the incremental test. If the verification
test had not been conducted, one participant would have been incorrectly classified as having
low cardiorespiratory fitness based on incremental test results alone. Conclusions: Verification
testing validates the attainment of VO  and can potentially reduce the over-diagnosis of
functional impairment (i.e., deconditioning) in adults with prehypertension.
Keywords: blood pressure (/search?q=blood%20pressure); aerobic fitness (/search?
q=aerobic%20fitness); 3-min all-out exercise test (/search?q=3-min%20all-
out%20exercise%20test); VO  (/search?q=VO2max); deconditioning (/search?
q=deconditioning)
1. Introduction
Prehypertension affects one in three adults in the United States [1] and is associated with
an increased risk of hypertension [2] as well as cardiovascular morbidity and mortality [3]. Low
cardiorespiratory fitness in adults with prehypertension is associated with an increased risk of
hypertension [4] and atherosclerosis [5]. Previous studies that have examined the associations
between cardiorespiratory fitness and health outcomes in adults with prehypertension have
typically quantified cardiorespiratory fitness relative to body weight (i.e., as mL·min ·kg ) or
metabolic equivalents (MET) or treadmill test duration, and they have used treadmill as the
mode of exercise for fitness assessments [4,6,7,8,9,10]. While treadmill testing per se may not














affect maximal oxygen uptake (VO ) levels, the use of exercise test duration from a treadmill
protocol as a surrogate for VO  can negatively influence performance in individuals who
carry excess body weight [11]. These traditional methods of quantifying cardiorespiratory fitness
could inaccurately underestimate fitness levels in individuals with overweight or obesity, who are
also at increased risk of high blood pressure [12], and can confound the associations between
cardiorespiratory fitness and negative health outcomes [13]. Both the American Thoracic Society
(ATS) [14] and the American Heart Association (AHA) [15] recommend quantifying
cardiorespiratory fitness as a percent of predicted VO , where predicted VO  is
calculated based on ideal body weight. This approach can reduce the underestimation of
cardiorespiratory fitness in overweight and obese individuals [16].
Cardiopulmonary exercise testing provides an assessment of VO  or the highest amount
of oxygen that can be delivered by the cardiorespiratory system and utilized by the skeletal
system. Hill and Lupton first suggested in 1923 that VO  represented a point during a graded
exercise test where VO  failed to increase despite an increase in work rate (WR) [17]. Since
then, the demonstration of a VO  plateau has become an essential marker for the achievement
of VO . Unfortunately, over 40 % of individuals do not achieve a VO  plateau during a
graded exercise test despite achieving VO  [18]. To overcome this limitation, verification
testing has been increasingly recommended for validating the achievement of VO  from an
incremental or graded exercise test in lieu of a VO  plateau [18]. However, the verification
testing approach has not been previously evaluated in adults with prehypertension, who could
benefit from the accurate measurements of cardiorespiratory fitness and consequently the
accurate prediction of chronic disease risk.
The purpose of this study was to quantify cardiorespiratory fitness based as a percent of
predicted VO  and to examine whether a supramaximal constant-load verification test
validates the attainment of VO  from an incremental test in adults with prehypertension.
Based on published data in recreationally trained adults [19] and adults with obesity [20], we
hypothesized that there would be no difference between incremental and verification test VO  in
adults with prehypertension.
2. Materials and Methods
The Valdosta State University Institutional Review Board approved this study (Protocol
number: IRB-03344-2016), and all participants provided written, informed consent. All
participants were 18–30-year-old, healthy, non-smoking adults with a body mass index (BMI)
between 20–30 kg·m . Participants with cardiovascular, renal, or metabolic disease were
excluded [21]. Height and weight were measured using calibrated scales. Resting blood




















arms. Thereafter, three BP measurements were taken in the left arm on two separate days using
an automated monitor (SunTech Tango M2 stress test monitor, SunTech Medical, Morrisville,
NC, USA) [22]. All participants had a resting systolic BP between 120–139 or a resting diastolic
BP between 80–89 mm Hg, which met the definition of “prehypertension” at the time of study
design [22]. Participants were asked to avoid caffeine and exercise for 24 h and food for 3 h
prior to all study visits.
2.1. Incremental Test
The incremental test was performed on an electronically braked cycle ergometer (Ergoline
VIAsprint 150P, Bitz, Germany). Participants completed a two-min warm-up at 30 Watt (W) for
women and 40 W for men. WR was increased in the third minute to 40 W for women and 50 W
for men. Thereafter, WR was increased by 20 W for women and 25 W for men every minute until
volitional exhaustion. Participants were asked to maintain cadence between 60–70 rpm, but
were allowed to increase cadence at higher WR, although they were not allowed to exceed a
cadence of 100 rpm. The test was stopped when participants were unable to maintain a
cadence of 50 rpm for five consecutive seconds despite encouragement.
2.2. Verification Test
The verification test was performed at least 15 min after the incremental exercise test. The
verification test was completed at 105% of the maximal WR from the incremental test until
volitional exhaustion. The participants warmed up by cycling for 2 min at 30 W for women or 40
W for men. WR was increased to 105% maximal WR immediately after the warm-up, and
participants were encouraged to pedal at a cadence of their choice between 60–100 rpm for as
long as possible. The test was stopped when participants were unable to maintain a cadence of
50 rpm for five seconds despite encouragement.
2.3. Measurements
Participants were fitted with an oronasal mask connected to a standard non-rebreathing
valve (Hans Rudolph, Shawnee, KS, USA). Minute ventilation (V ) and gas exchange (VO  and
carbon dioxide production, VCO ) were measured with a metabolic measurement system and
reported as 20-s averages (TrueOne 2400, Parvo Medics, Sandy, UT, USA). A standard three-
point calibration was performed before each test or every 4 h per manufacturer
recommendations. Heart rate (HR) was measured continuously (Polar Electro Inc., Bethpage,
NY, USA). Ratings of perceived breathlessness (RPB; Borg 0–10 scale) and ratings of perceived
exertion (RPE; Borg 6–20 scale) were assessed every min [23]. The highest VO  from the










Data from each test were processed as explained below:
1. Attainment of VO  plateau during the incremental test: For each incremental test, an
assessment was made regarding the achievement of a VO  plateau [24,25]. First, we
completed a regression of the VO  and WR relationship after excluding the first and last
minute of data. Next, we calculated the “expected” increase in VO  from the penultimate to the
final stage using the VO /WR regression. Finally, achievement of VO  plateau was accepted
when the difference between measured VO  between the penultimate and final stage was
less than 50% of the “expected” increase.
2. Difference in VO  between incremental and verification tests: To evaluate whether the highest
VO  during the verification test truly exceeded the highest incremental VO , we calculated the
“expected” verification VO  at 105% of maximum WR using the VO /WR regression from the
incremental test as stated above. If the measured verification VO  was equal to or exceeded
the “expected” verification VO , we concluded that the participant achieved a higher VO
during the verification test.
3. Time taken to reach highest VO  during the verification test: Segmental regression analyses
were conducted in Prism 8 (version 8.4.2, GraphPad Software, San Diego, CA, USA) to
estimate the time at which the VO  reached a “plateau” during the verification test. A similar
assessment was conducted in Microsoft Excel (version 2011, Microsoft, Redmond, WA, USA)
using visual inspection of the VO  (L·min ) versus time (s) plot to compare the two methods
(i.e., Prism 8 vs. visual inspection in Excel).
4. Quantification of cardiorespiratory fitness: VO  was predicted for each participant using
equations from Hansen and Wasserman, with age of 30 years used for adults younger than 30
years [16]:
Men:
Ideal weight (kg) = 0.79 × Height (cm) − 60.7
If actual weight equaled or exceeded ideal weight:
VO  = 0.0337 × Height (cm) − 0.000165 × Age × Height (cm) − 1.963 + 0.006 × Weight
(actual − ideal)
If actual weight was less than ideal weight:
VO  = 0.0337 × Height (cm) − 0.000165 × Age × Height (cm) − 1.963 + 0.014 × Weight
(actual − ideal)
Women:
Ideal weight (kg) = 0.65 × Height (cm) − 42.8
VO  = 0.001 × Height (cm) × (14.783 − 0.11 × Age) + 0.006 × Weight (actual − ideal)
Percent predicted VO  was calculated as measured/predicted × 100. For % predicted


























With an effect size of 1.069 based on previously published data [25] and an alpha of 0.05, a
sample size of 11 participants would be able to detect a difference between incremental and
verification VO  using a Wilcoxon signed-rank test with a power of 0.87. Mann–Whitney U tests
were used to compare sex differences. Wilcoxon signed-rank tests were used to compare
differences in variables between maximal and verification tests. Fisher’s exact test was used to
examine proportional differences between sexes. Kendall’s tau-b (τb) was used to examine
associations between variables. Analyses were completed with SPSS software (version 27, IBM,
Armonk, NY, USA). In this study, p < 0.05 was considered statistically significant.
3. Results
Participant characteristics are shown in Table 1. Six participants were normal weight (BMI
18.5–24.9 kg·m ) and five were overweight (BMI 25–29.9 kg·m ). Women had higher diastolic
blood pressure when compared with men (Table 1). WR  was higher in men when compared
with women (Table 1).
Table 1. Participant characteristics reported as mean ± SD.
3.1. Incremental Test
Seven participants (64%) achieved a VO  plateau during the incremental exercise test
(Table 2). Three out of four women did not achieve a VO  plateau during the incremental test,
although their peak HR and respiratory exchange ratio (RER) were high, which indicated that
they were approaching exhaustion (Table 2). One out of seven men did not achieve a VO
plateau. This participant had the highest BMI in the group, and his HR and RER responses
indicate that he may have experienced fatigue prior to achieving VO  (Table 2).













The verification test duration for participants in this study was 127 ± 20 s (see individual
responses in Table 2). Estimates for time taken to reach a plateau during the verification test
from Prism 8 and visual inspection in Excel were not statistically different (59 ± 13 and 60 ± 13 s;
p = 0.929; Wilcoxon signed-rank test), suggesting that both methods can be used to determine
the presence of a VO  plateau in a verification test. The minimum duration of the verification test
in this study was 96 s, which was above the maximum time taken to attain a VO  plateau from
both Prism 8 (72 s) and visual inspection methods (80 s). VO  (L·min ) was significantly
correlated with verification test duration (τb = 0.636, p = 0.006). The difference in VO  between
incremental and verification tests was not significantly correlated with the verification test
duration (τb = 0.309, p = 0.186).
3.3. Incremental vs. Verification Test
Only three out of eleven participants (27%) had a higher VO  during the verification test
when compared with the incremental test based on the “expected” VO  from the VO /WR
regression. For one participant, the difference between incremental and verification test VO
was 144 mL·min , despite achieving a VO  plateau during the incremental test (Table 2).
However, the other two participants did not achieve a VO  plateau during the incremental test
and had differences of 213 mL·min  and 252 mL·min  between the incremental and
verification test VO .
On average, respiratory exchange ratio (RER), calculated as VCO /VO , was higher during
the incremental when compared with the verification test (Table 3). RER increases during high-
intensity exercise due to bicarbonate buffering of hydrogen ions (i.e., metabolic acidosis), which
increases the rate of CO  production out of proportion to O  consumption [16]. There were no
statistically significant differences for VO , VCO , V , HR, or breathing pattern between the
incremental and verification tests (Table 3).




















3.4. Quantification of Cardiorespiratory Fitness
Using the highest VO  (% predicted) from either the incremental or verification test, we
found that two out of eleven participants had below normal levels of cardiorespiratory fitness
(i.e., VO  ≤ 84% predicted; Table 2). If the verification test had not been conducted, one
more participant would have been incorrectly classified as having below normal
cardiorespiratory fitness (i.e., VO  ≤ 84% predicted) based on incremental test results alone
(Table 2). This participant had not achieved a VO  plateau during the incremental test.
3.5. Predictors of Maximal Oxygen Uptake
Total body mass tended to be associated with absolute VO  in all participants (Figure 1;
p = 0.073). There were no significant associations between cardiorespiratory fitness (i.e.,
VO  quantified as % predicted) and age, anthropometrics, or blood pressure in the total
study sample. Cardiorespiratory fitness was inversely associated with total body mass in women
(Figure 1f).
Figure 1. Relationship between total body mass and (a) absolute maximal oxygen uptake
(VO ), (b) relative VO , and (c) VO  quantified as % predicted for all study
participants. Relationship between total body mass and (d) absolute VO , (e) relative
















A two-step protocol that includes both incremental and verification testing for the
measurement of VO  can confirm the attainment of VO  in adults with prehypertension.
Relying on the incremental test alone could underestimate true VO  in ≈27% of individuals
and could result in misdiagnosing individuals with prehypertension as “deconditioned”. From a
methodological standpoint, 80 s represented the longest duration taken for participants to reach
a VO  plateau during a supramaximal constant-load verification test completed at 105% of
WR .
Accurate assessments of VO  are critical to risk prediction models in epidemiology as
well as for assessing changes in cardiorespiratory fitness after exercise interventions. Therefore,
studies in relatively healthy populations who are not at risk of a “symptom-limited” exercise test
[26] should consider a two-step protocol that can be completed during a single visit for
confirming VO . In this study, a two-step protocol was successfully completed in 11 young
adults with prehypertension. We reported a higher verification VO  when compared with
incremental VO  in three out of eleven participants.
To determine if there is a meaningful difference in VO  between incremental and verification
tests, researchers must consider VO  measurement error, which is estimated at 40 mL·min  for
the Parvo Medics TrueOne 2400 [27], and also consider the possibility that a participant may
have terminated the incremental test prior to achieving VO . The present study predicted the
expected VO  at maximal and supramaximal WRs from the individual participants’ VO /WR
regression and then compared the measured difference between incremental and verification
VO  against the predicted difference. Had this approach not been used in the present study,
seven out of eleven participants would have been identified with having a higher verification
when compared with incremental VO . For four of these seven participants, the difference
between incremental and verification tests ranged from 2 to 73 mL·min . Alternatively, Midgley
et al. [28] considered a ≤2% difference between incremental and verification VO  as a criterion
for verifying VO  based on the measurement error in determining VO . Had the present
study used the 2% criterion, one additional participant with the 73 mL·min  difference (≈4%)
would have had a higher verification VO  when compared with the incremental VO .
Four out of eleven participants, three of whom were women, did not achieve a VO  plateau
during the incremental test in this study. This is consistent with other reports that have
demonstrated a failure to achieve a VO  plateau even when true VO  is achieved in healthy
men [24,29,30]. Day et al. [24] noted the absence of a VO  plateau during an incremental test in
83% of 71 men. This was similar to results by Rossiter et al. [29] in a smaller sample, where five
out of seven men demonstrated no plateau (i.e., 71.4%). Poole et al. [30] noted the absence of a
VO  plateau in three out of eight male subjects (i.e., 38.5%). Sidney and Shephard [31] reported




























incremental test, achieved a VO  plateau (defined as a ≤2mL·min ·kg  increase in VO  with
an increase in WR). Based on the very limited sample of women in the present study, it is
difficult to speculate if sex differences exist with respect to VO  plateau achievement in
prehypertensive adults. However, it should be noted that the original concept of the VO  plateau
was derived from multiple constant-load tests and a plateau was accepted when VO  did not
differ between two consecutive tests with differing WR [24]. Therefore, a VO  plateau
requirement in a ramp test does not mimic the original concept. In two of the four participants
who did not achieve a VO  plateau during the incremental test, true VO  had been achieved,
while in the other two, the verification test yielded a higher VO . The secondary criteria for
VO , which include the achievement of >85% of age-predicted maximum heart rate and an
RER of >1.15, were present in three out of four participants who did not achieve a VO  plateau
and in two out of three participants who achieved their VO  during the verification test. Taken
together, these results agree with findings from Poole et al. [30] and the subsequent
recommendation of rejecting secondary criteria to validate VO  from incremental exercise
tests.
The selected WR during the verification test must be sustainable for a sufficient duration
such that VO  kinetics allow for the achievement of VO  [18]. Wilkerson et al. [32] reported a
decrease in test duration from 100% to 110% to 120% of VO  but did not report significant
differences in VO  (% peak) between these exercise sessions. In the present study, all
participants achieved a VO  plateau 80 s into the verification test. However, for two participants,
verification VO  was at least 2% lower than incremental VO , which suggests that oxygen
delivery or utilization was likely limited prior to achievement of VO  during the verification test
in these participants.
Midgley et al. [28] reported that in four men who had a higher verification VO  when
compared with incremental VO , all four had achieved a VO  plateau during the incremental
test. In the present study, of the three participants who had a higher verification VO  when
compared with incremental VO , only one had achieved a VO  plateau during the incremental
test. It is apparent, from these limited findings, that the achievement of a VO  plateau during the
incremental test does not preclude a higher verification VO . The three participants with a higher
verification VO  when compared with incremental VO  in the present study exhibited a slightly
longer verification test duration (142 ± 19 s) when compared with the eight participants without a
higher verification VO  (121 ± 19 s; p = 0.133; Mann–Whitney U test). A longer test duration
could potentially explain the higher verification VO . However, it is also possible that faster VO
kinetics during the verification test as well as a priming effect from the previous incremental test
[33] allowed for the attainment of VO  during the verification test but not during the
incremental test for these three participants.
The average VO  in the current study of 88.8 ± 7.4% predicted is consistent with
estimates of 89.7 ± 25.7% predicted from Jung et al. in 377 adults with prehypertension [34]. As
































noted in the introduction, quantifying VO  relative to body weight can significantly
underestimate cardiorespiratory fitness in overweight and obese individuals, in whom
metabolically inactive fat mass is unable to utilize oxygen during exercise [13,35]. It may be
prudent to adopt the approach of quantifying cardiorespiratory fitness as a percent of predicted
based on ideal body weight to get an unbiased estimate of cardiorespiratory fitness [13,14,15].
Although the current project was not a large epidemiological study, it does provide an accurate
assessment of cardiorespiratory fitness that is not confounded by body mass in prehypertensive
normal-weight and overweight men and women. These results are important for future work in
the area of cardiorespiratory fitness, underlying comorbidities, and disease risk prediction.
This study had a small sample size and an uneven sex distribution, which precluded the
analysis of sex differences. Furthermore, comparisons by overweight status were also not
possible due to limited sample size. Finally, the AHA removed the term “prehypertension”
towards the end of 2017. The new AHA guidelines classify systolic BP between 120 and 129
mm Hg and diastolic BP below 80 mm Hg as “elevated” BP and systolic BP between 130 and
139 mm Hg or diastolic BP between 80 and 89 mm Hg as stage 1 hypertension [36]. Based on
this new definition, nine participants in this study would be classified with “elevated” BP and two
with stage 1 hypertension. Despite these limitations, this study has several strengths, which
include the confirmation of VO  using a verification test in adults with prehypertension,
careful examination of individual test data for attainment of a VO  plateau, and the quantification
of VO  based on ideal body weight in normal-weight and overweight prehypertensive men
and women.
5. Conclusions
Our data confirms that verification testing is feasible, validates the attainment of VO ,
and can potentially reduce the over diagnosis of functional impairment (i.e., deconditioning) in
adults with prehypertension. Clinicians and researchers who routinely evaluate cardiorespiratory
fitness in adults with prehypertension could consider verification testing as well as the
quantification of cardiorespiratory fitness as a percent of predicted based on ideal body weight to
achieve an unbiased and accurate estimate of cardiorespiratory fitness. This approach could
help identify prehypertensive adults with low cardiorespiratory fitness who would benefit from
exercise interventions to increase cardiorespiratory fitness and to reduce the risk of developing
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